Aprea Therapeutics, Inc. (APRE)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $30k
- Oct 18 · No plan
- Form 4 sales
- 19
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualSep 20, 2021 2021
Sold 25,000 shares at $4.97 ($124k)
Abrahmsen Lars B., SVP, Chief Scientific Officer
Sold 56.8% of holdings ($219k position)19,000 shares leftFirst sale on recordFiling
- 2 Form 4 saleUnusualSep 20, 2021 same day
Sold 32,960 shares at $4.97 ($164k)
Korbel Gregory Alan, SVP, Chief Business Officer
Sold 65.8% of holdings ($249k position)17,167 shares leftFirst sale on recordFiling
- 3 Form 4 saleUnusualOct 1, 2021 +11 days
Sold 27,500 shares at $4.89 ($134k)
Korbel Gregory Alan, SVP, Chief Business Officer
Sold 61.6% of holdings ($218k position)17,167 shares leftFiling
- 4 Form 4 saleUnusualOct 1, 2021 same day
Sold 50,000 shares at $4.89 ($244k)
Abrahmsen Lars B., SVP, Chief Scientific Officer
Sold 72.5% of holdings ($337k position)19,000 shares leftFiling
- 5 Form 4 saleUnusualNov 1, 2021 +31 days
Sold 27,500 shares at $5.00 ($138k)
Korbel Gregory Alan, SVP, Chief Business Officer
Sold 61.6% of holdings ($223k position)17,167 shares leftFiling
- 6 Form 4 saleUnusualDec 1, 2021 +30 days
Sold 27,500 shares at $3.96 ($109k)
Korbel Gregory Alan, SVP, Chief Business Officer
Sold 61.6% of holdings ($177k position)17,167 shares left1x usual sizeFiling
- 7 Form 4 saleUnusualFeb 28, 2022 +89 days
Sold 36,000 shares at $1.73 ($62k)
Attar Eyal C., SVP, Chief Medical Officer
Sold 43.4% of holdings ($144k position)47,000 shares leftFiling
- 8 Form 4 saleNo planOct 18, 2024 +963 days
Sold 6,462 shares at $4.58 ($30k)
Duey Marc, Director
No 10b5-1 planSold 2.7% of holdings ($1.1M position)233,651 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (19)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2024 | Oct 25, 2024 | Duey Marc | APRE | Director | Form 4 sale | 6,462 | $30k | 2.7% | No plan | SEC |
| Feb 28, 2022 | Mar 1, 2022 | Attar Eyal C. | APRE | SVP, Chief Medical Officer | Form 4 sale | 36,000 | $62k | 43.4% | Unusual | SEC |
| Dec 1, 2021 | Dec 3, 2021 | Korbel Gregory Alan | APRE | SVP, Chief Business Officer | Form 4 sale | 27,500 | $109k | 61.6% | Unusual | SEC |
| Nov 1, 2021 | Nov 3, 2021 | Korbel Gregory Alan | APRE | SVP, Chief Business Officer | Form 4 sale | 27,500 | $138k | 61.6% | Unusual | SEC |
| Oct 1, 2021 | Oct 5, 2021 | Abrahmsen Lars B. | APRE | SVP, Chief Scientific Officer | Form 4 sale | 50,000 | $244k | 72.5% | Unusual | SEC |
| Oct 1, 2021 | Oct 5, 2021 | Korbel Gregory Alan | APRE | SVP, Chief Business Officer | Form 4 sale | 27,500 | $134k | 61.6% | Unusual | SEC |
| Sep 20, 2021 | Sep 22, 2021 | Korbel Gregory Alan | APRE | SVP, Chief Business Officer | Form 4 sale | 32,960 | $164k | 65.8% | Unusual | SEC |
| Sep 20, 2021 | Sep 22, 2021 | Abrahmsen Lars B. | APRE | SVP, Chief Scientific Officer | Form 4 sale | 25,000 | $124k | 56.8% | Unusual | SEC |
| Sep 16, 2021 | Sep 20, 2021 | Attar Eyal C. | APRE | SVP, Chief Medical Officer | Form 4 sale | 15,968 | $75k | 16.1% | Plan not stated | SEC |
| Dec 28, 2020 | Feb 16, 2021 | Redmile Group, LLC | APRE | 10% owner | Form 4 sale | 500,000 | $2.8M | 22.0% | Plan not stated | SEC |
| Oct 5, 2020 | Oct 7, 2020 | 5AM Opportunities I (GP), LLC | APRE | Other | Form 4 sale | 175,000 | $4.4M | 55.8% | Unusual | SEC |
| Jul 7, 2020 | Jul 7, 2020 | KCIF Co-Investment Fund KB | APRE | 10% owner | Form 4 sale | 241,703 | $8.4M | 10.8% | Plan not stated | SEC |
| Jun 16, 2020 | Jun 18, 2020 | Rocklage Scott M | APRE | Director, 10% owner | Form 4 sale | 120,164 | $4M | 61.3% | Unusual | SEC |
| Jun 16, 2020 | Jun 18, 2020 | 5AM Opportunities I (GP), LLC | APRE | 10% owner | Form 4 sale | 140,000 | $4.7M | 30.9% | Unusual | SEC |
| Jun 11, 2020 | Jun 15, 2020 | Rocklage Scott M | APRE | Director, 10% owner | Form 4 sale | 245,000 | $7M | 75.2% | Unusual | SEC |
| Jun 11, 2020 | Jun 15, 2020 | 5AM Partners IV, LLC | APRE | 10% owner | Form 4 sale | 245,000 | $7M | 75.2% | Unusual | SEC |
| May 19, 2020 | May 21, 2020 | Rocklage Scott M | APRE | Director | Form 4 sale | 255,000 | $9M | 73.8% | Unusual | SEC |
| May 19, 2020 | May 21, 2020 | 5AM Partners IV, LLC | APRE | 10% owner | Form 4 sale | 255,000 | $9M | 73.8% | Unusual | SEC |
| Apr 13, 2020 | Apr 15, 2020 | KDev Investments AB | APRE | 10% owner | Form 4 sale | 210,548 | $6.6M | 8.6% | Plan not stated | SEC |